We at 3M know patient comfort and satisfaction is of utmost importance and we devote our days to developing smart skin care solutions to protect and maintain the skin from conditions ranging from Incontinence-Associated Dermatitis and MARSI to Periwound protection.
Incontinence-Associated Dermatitis (IAD) affects patients in both acute and long-term care settings. This skin-damage condition is associated with exposure to urine or stool. Patients experience considerable discomfort and the condition can be difficult, time consuming, and expensive to treat. IAD is a significant worldwide health challenge and is a commonly accepted risk factor for pressure ulcer development1.
We, at 3M, partnered with Wounds International to convene a panel of experts to draft evidence-based best practices for identifying, preventing, and treating IAD. This panel’s published work specifically addressed the importance of establishing a globally-accepted skin care protocol.
Access your copy of Moving Prevention Forward: Incontinence-Associated Dermatitis Best Practice Principles (PDF, 874 KB)
Curious how 3M™ Cavilon™ Skin Care Solutions can help your patients? Read more here.
Learn more about Incontinence-Associated Dermatitis and Cavilon solutions
1. Beeckman D et al. Proceedings of the Global IAD Expert Panel. Incontinence associated dermatitis: moving prevention forward. Wounds International 2015 External
3M has more than 70 pieces of clinical evidence supporting the efficacy and cost-effectiveness of Cavilon No Sting Barrier Film—more evidence than any other moisture barrier or barrier film.
One study compared the durability of four barrier film products and found after 72 hours of wear, Cavilon No Sting Barrier Film was more than twice as effective at preventing wash-off and wear-off of a marker substance from the skin compared to Medline Sureprep® No-Sting Skin Protectant.2
Read the full study: A comparison of the durability of four barrier film products over a 72 hour period on human volunteers
2. A comparison of the durability of four barrier film products over a 72 hour period on human volunteers. Houser T, Grove GL, Zerweck C, Poster presentation at the Clinical Symposium for Advances in Skin and Wound Care (CSASWC); 2010.
Medical Adhesive Related Skin Injuries (MARSI) can be a serious complication that can be prevented and managed. MARSI occurs across all care settings and age groups yet these injuries do not have to considered an inevitable outcome of patient care. At 3M we provide solutions for preventing and managing a patient’s skin injury including skin tears.
Learn more about MARSI and products to help in the prevention of MARSI
Medical Adhesive-Related Skin Injury (MARSI) refers to the red irritated skin that often occurs when medical adhesives are removed. It occurs across all care settings and age groups, often due to improper selection, application or removal of medical adhesives. This causes unnecessary pain to patient's and compromises skin integrity.
With an impressive history in developing adhesive solutions, we at 3M have a unique understanding of how adhesives interact with skin. We use that knowledge to develop products to address patient needs in today’s care setting — and reduce the risk of MARSI.
Incontinence-Associated Dermatitis (IAD) is a painful, problematic skin injury that results from exposure to urine or feces. This is a miserable patient experience that also increases the risk of complications.
A global panel of experts concluded that a structured skin care regimen is key to maintaining the skin integrity of patients at risk for IAD.
3M™ Cavilon™ Skin Care Solutions -- including our new, innovative 3M™ Cavilon™ Advanced Skin Protectant -- are key to a skin care regimen that protects patients, even in cases of moderate to severe IAD.
Patients with infected wounds or venous leg ulcers (VLUs) and associated edema are especially at risk of periwound skin damage.
Excessive hydration of periwound skin compromises the barrier function, making the epidermis more vulnerable to MARSI and damage from friction.
Peristomal skin damage risk is a result of the challenge of caring for an ostomy. Skin injury is common, affecting up to 55% of patients with fecal diversions*. Patients with a problem stoma and/or high output are especially vulnerable.
*Lyons C, Smith AJ. (2003). Abdominal Stomas and their Skin Conditions.